3-(3-Chloro-2-Methoxyanilino)-2-{3-[(2S)-1,4-Dioxan-2-Ylmethoxy]Pyridin-4-Yl}-1,5,6,7-Tetrahydro-4H-Pyrrolo[3,2-C]Pyridin-4-One

2 trials 2 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

2 Sponsors

18 Countries

Phase III

Phase II

Phase III: 1 Phase II: 1

Indications tested

EGFR gene mutation 2 Malignant neoplasm of ampulla of Vater 1 Sarcoma 1 Bile duct cancer 1 Gastric cancer 1 Salivary gland cancer 1 Colorectal cancer 1 Ovarian cancer 1 Breast cancer 1 Gallbladder cancer 1 Non-small cell lung cancer 1 Bladder cancer 1

Sponsors using this IMP

Bayer AG 2 Bayer Consumer Care AG 1

All trials

2 total

A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so… Recruiting

2024-517419-62-00 Phase II 4 countries Bayer AG; Bayer Consumer Care AG
A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc… Recruiting

2024-511319-91-00 Phase III 18 countries Bayer AG

Showing 1–2 of 2 trials

← All drugs A–Z